chr3-49534029-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004393.6(DAG1):​c.*830G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.238 in 152,586 control chromosomes in the GnomAD database, including 4,618 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).

Frequency

Genomes: 𝑓 0.24 ( 4604 hom., cov: 33)
Exomes 𝑓: 0.24 ( 14 hom. )

Consequence

DAG1
NM_004393.6 3_prime_UTR

Scores

2

Clinical Significance

not provided no classification provided O:1

Conservation

PhyloP100: 2.10

Publications

19 publications found
Variant links:
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2P
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated asymptomatic elevation of creatine phosphokinase
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.265 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DAG1NM_004393.6 linkc.*830G>T 3_prime_UTR_variant Exon 3 of 3 ENST00000308775.7 NP_004384.5 Q14118A0A024R2W4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DAG1ENST00000308775.7 linkc.*830G>T 3_prime_UTR_variant Exon 3 of 3 1 NM_004393.6 ENSP00000312435.2 Q14118

Frequencies

GnomAD3 genomes
AF:
0.238
AC:
36121
AN:
151976
Hom.:
4591
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.269
Gnomad AMI
AF:
0.269
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.192
Gnomad EAS
AF:
0.00866
Gnomad SAS
AF:
0.0863
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.277
Gnomad NFE
AF:
0.267
Gnomad OTH
AF:
0.249
GnomAD4 exome
AF:
0.236
AC:
116
AN:
492
Hom.:
14
Cov.:
0
AF XY:
0.268
AC XY:
81
AN XY:
302
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.143
AC:
2
AN:
14
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.125
AC:
1
AN:
8
European-Finnish (FIN)
AF:
0.168
AC:
36
AN:
214
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.310
AC:
77
AN:
248
Other (OTH)
AF:
0.00
AC:
0
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.238
AC:
36165
AN:
152094
Hom.:
4604
Cov.:
33
AF XY:
0.230
AC XY:
17087
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.269
AC:
11168
AN:
41470
American (AMR)
AF:
0.192
AC:
2931
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
664
AN:
3464
East Asian (EAS)
AF:
0.00849
AC:
44
AN:
5182
South Asian (SAS)
AF:
0.0863
AC:
417
AN:
4830
European-Finnish (FIN)
AF:
0.182
AC:
1925
AN:
10586
Middle Eastern (MID)
AF:
0.284
AC:
83
AN:
292
European-Non Finnish (NFE)
AF:
0.267
AC:
18169
AN:
67970
Other (OTH)
AF:
0.246
AC:
520
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1408
2816
4225
5633
7041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.254
Hom.:
804
Bravo
AF:
0.240
Asia WGS
AF:
0.0670
AC:
234
AN:
3478

ClinVar

Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link

Submissions by phenotype

not provided Other:1
May 13, 2011
Leiden Muscular Dystrophy (DAG1)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
14
DANN
Benign
0.80
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12583; hg19: chr3-49571462; API